Symposium:
82. Multi-Resistant Gram Negative Infections: The Baddest of the Bad
Friday, October 22, 2010: 2:00 PM-4:00 PM
East Exhibit Hall

Learning Objectives:

Based on participation in this symposium, participants will be able to implement the following in their practices:

  • Identify challenges in treating emerging pathogens linked to healthcare delivery
  • Take steps to prevent transmission of emerging pathogens linked to healthcare delivery 

Target Audience: Infection control practitioners, Scientists, Researchers, Public Health Practitioners, Pharmacists, Microbiologists, Lab Personnel, Infectious Disease Physicians, Infectious Disease Pediatricians, Infection Preventionists, Hospital Epidemiologists, Hospital Administrators, Fellows-in-Training/Fellows, Epidemiologists, Clinicians, Academicians

Topical Category: N. Hospital-acquired and surgical infections, infection control, and health outcomes including general public health and health services research

Tracks: Adult ID

CME Credits: CME Maximum of 2.0 hours of Category 1 credit possible

ACPE Credits: ACPE Maximum of 2.0 hours of Pharmacy CE credit possible

ACPE Number: 0245-9999-10-047-L01-P (Application)

Moderators:  Paul Tambyah, MD, National University of Singapore and Lisa Maragakis, MD, Johns Hopkins University

Disclosures:

P. Tambyah, Yes
Baxter: Investigator, Research support
Adamas: Investigator, Research grant and Research support
Merlion Pharma: Investigator, Research support
Asia Pacific Advisory Committee on Influenza: Board Member, Travel expenses
Novartis: Speaker- Honorarium, Speaker honorarium
Astra-Zeneca: Speaker - honorarium, Speaker honorarium

L. Maragakis, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 21 with the exception of research findings presented at IDSA press conferences.

 
 
   
 

Copyright IDSA 2009 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org